Professionals

Technology Areas

Practice Areas

Honors

  • Alabama Law Review, Junior Editor 2012–13 & Senior Editor 2013–14
  • Best Paper: ANTITRUST, May 2012, University of Alabama School of Law
  • Best Paper: CRIMINAL LAW, Dec. 2011, Cumberland School of Law
  • Best Paper: LEGAL WRITING, Dec. 2011, Cumberland School of Law
  • Graduate Student of the Year, May 2000, University of Alabama Birmingham Chemistry Department

Admissions

  • Alabama, 2014
  • U.S. Patent and Trademark Office, 2013

Education

University of Alabama School of Law, J.D., 2014

University of Alabama Birmingham, Birmingham, Alabama, Ph.D., Organic Chemistry, 2001
Thesis: Design of conformationally defined retinoids: synthesis, nuclear receptor binding, and transcriptional activity of derivatives of (9Z)-UAB30

University of Alabama, B.S., Chemistry, 1993

Teaching Positions

  • Teaching Assistant: General Chemistry, Biochemistry and Organic Chemistry (1995-2001)
Photo of Kimberly  Vines, Ph.D.

Kimberly Vines, Ph.D.

Associate
Atlanta
404.607.9991
Email

Kimberly’s expertise is in prosecuting U.S., foreign, and international applications with a main focus in the areas of chemicals, small molecule pharmaceuticals and biotechnology.  She practices all aspects of patent prosecution including non-infringement opinions. Kimberly’s doctoral thesis was directed to the design and synthesis of novel RXR-selective retinoids as breast cancer chemopreventive agents. Her post-doctoral research was directed to the synthesis of natural products such as Epothilone B and Pseudolaric Acid B as well as anti-malarial compounds. Prior to practicing law, Kimberly worked as a chemist at several companies in the greater Boston area.

Experience Highlights

Associate, Cantor Colburn LLP, 2018-present

Patent Attorney, Bradley Arant Boult Cummings, LLP, Birmingham, AL, 2015-2018

Project Leader, Creagen Biosciences, Woburn, MA, 2007-2011

Scientist I, GPC Biotech, Waltham, MA, 2006-2007

Contract Chemist, Infinity Pharmaceuticals, Cambridge, MA, 2006

Investigator I, ArQule, Inc., Woburn, MA, 2005-2006

Postdoctoral Research Scientist, University of Mississippi, 2001-2005

Publications

Further Erosion of Patent Protection for Diagnostics: The Federal Circuit Denies En Banc Rehearing in Ariosa Diagnostics, Inc. v. Sequenom, Inc. (co-authored with Alice Martin of Barnes & Thornburg), AIPLA Quarterly Journal, Vol. 44, No. 3 (Summer 2016), pp. 437−458.

Federal Circuit Reduces CertaintyMultilayer Stretch Film Holdings, Inc. v. Berry Plastics Corp., CHEMICAL PRACTICE CHRONICLES, Fall 2016, pp. 16−21.

Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention, BIOORGANIC & MEDICINAL CHEMISTRY, 22, 178-85 (2014).

Syntheses of Benzo[b]furan-6-carbonitrile and 6-cyanobenzo[b]furan-2-boronic acid pinacol ester, SYNTHETIC COMMUNICATIONS, 43(14), 1974−1979 (2013).

Total syntheses of Epothilones B and D, JOURNAL OF ORGANIC CHEMISTRY, 69 (26), 9269–84 (2004).

Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-Dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7- dimethyl-2,4,6-octatrienoic Acid (9cUAB30), JOURNAL OF MEDICINAL CHEMISTRY, 46 (17), 3766–69 (2003).

9cUAB30, an RXR-specific retinoid, and/or Tamoxifen in the prevention of methylnitrosourea-induced mammary cancers, CANCER LETTERS, 201 (1), 17–24 (2003).

Chemistry Presentations:

Convenient one-pot synthesis of 4-substituted-2,6-dihalopyridines: valuable building blocks for medicinally active heterocycles, Abstracts of Papers, 240TH AM. CHEM. SOC’Y NAT’L MEETING, Boston, MA (2010).

Progress towards the total synthesis of Pseudolaric acid B: a novel antipneumocystic and antifungal natural product, Abstracts of Papers, 228TH AM. CHEM. SOC’Y NAT’L MEETING, Philadelphia, PA (2004).

Total synthesis of Epothilones B and D amenable to large-scale preparation, Abstracts of Papers, 225th AM. CHEM. SOC’Y NAT’L MEETING, New Orleans, LA (2003).

Synthesis of 1-aryl-7-substituted phthalazines as parasite cysteine protease inhibitors, Abstracts of Papers, 225th AM. CHEM. SOC’Y NAT’L MEETING, New Orleans, LA (2003).

Synthesis and breast cancer chemoprevention for UAB30 and analogs, receptor-selective retinoids, Book  of Abstracts, 218th AM. CHEM. SOC’Y NAT’L MEETING, New Orleans, LA (1999).

LEGAL PUBLICATIONS

Further Erosion of Patent Protection for Diagnostics: The Federal Circuit Denies En Banc Rehearing in Ariosa Diagnostics, Inc. v. Sequenom, Inc. (co-authored with Alice Martin of Barnes & Thornburg), AIPLA QUARTERLY JOURNAL, Vol. 44, No. 3 (Summer 2016), pp. 437−458.

Federal Circuit Reduces Certainty – Multilayer Stretch Film Holdings, Inc. v. Berry Plastics Corp., CHEMICAL PRACTICE CHRONICLES, Fall 2016, pp. 16−21.

LEGAL BLOG POSTINGS

You’ll Have To Be More Specific When Crafting That Generic Claim, PATENT 213 (Nov. 9, 2016, 3:59).

Professional Affiliations

Intellectual Property Owners Association (IPO) 

American Intellectual Property Law Association (AIPLA)

American Chemical Society

Community/Civic Involvement

Alabama Volunteer Lawyer Program, 2014–2018

Birmingham Bar Volunteer Lawyer's Program, 2015−2018